Related Experiment Video
Updated: May 19, 2026
08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis
Benjamin C Cheah1, Cindy S Y Lin, Susanna B Park
1Neuroscience Research Australia, Sydney, New South Wales, Australia. M.Kiernan@unsw.edu.au
Summary
Amyotrophic lateral sclerosis (ALS) patients show increasing K(+) channel dysfunction in motor axons over time. These axonal excitability changes correlate with motor unit loss and functional impairment, offering insights into disease progression.
Area of Science:
- Neuroscience
- Neurology
- Physiology
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
- Understanding longitudinal changes in axonal function is crucial for elucidating ALS pathogenesis.
- Axonal excitability techniques offer a window into ion channel function in living neurons.
Purpose of the Study:
- To investigate longitudinal changes in axonal excitability in ALS patients.
- To correlate these changes with motor unit loss and functional decline.
- To identify early markers of axonal dysfunction in ALS.
Main Methods:
- 37 ALS patients underwent axonal excitability testing at baseline and 12-week follow-up.
- Measurements included depolarizing threshold electrotonus and superexcitability.
- Compound muscle action potential (CMAP) amplitude was assessed to evaluate motor unit integrity.
Main Results:
- Significant increases in K(+) channel dysfunction were observed over 12 weeks.
- Depolarizing threshold electrotonus and superexcitability parameters showed significant worsening.
- More severe axonal excitability changes preceded significant CMAP amplitude decline, indicating early axonal dysfunction.
Conclusions:
- Longitudinal axonal excitability studies reveal progressive K(+) channel dysfunction in ALS motor axons.
- Axonal dysfunction, as measured by excitability, is linked to functional impairment and motor unit loss in ALS.
- These findings highlight the utility of axonal excitability for studying disease mechanisms and potential therapeutic targets in ALS.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...